Myung Jeong

Showing 1-8 of 8 articles

A prospective, multicentre, randomised, open-label trial to compare the efficacy and safety of clopidogrel versus ticagrelor in stabilised patients with acute myocardial infarction after percutaneous coronary intervention: rationale and design of the TALOS-AMI trial

Park M, Kim C, Kim M, Choo E, Hwang B, Park C, Kim H, Yoo K, Jeon D, Jeong M, Seung K, Ahn Y, Chang K

February 19, 2021 | 10.4244/EIJ-D-20-00187

Coronary interventions

A Prospective, Multicenter, Randomized, Open-label Trial to Compare Efficacy and Safety of Clopidogrel vs. Ticagrelor in Stabilized Patients with Acute Myocardial Infarction after Percutan eous Coronary Intervention: rationale and design of the TALOS-AMI trial

Park M, Kim C, Kim M, Choo E, Hwang B, Park C, Kim H, Yoo K, Jeon D, Jeong M, Seung K, Ahn Y, Chang K

July 28, 2020 | 10.4244/EIJ-D-20-00187

Coronary interventions

Multivessel percutaneous coronary intervention in patients with acute myocardial infarction and severe renal dysfunction

Song P, Hahn J, Gwon H, Jeon K, Yu C, Rha S, Yoon C, Jeong M

December 6, 2019 | 10.4244/EIJ-D-19-00034

Coronary interventions

Impact of calcified bifurcation lesions in patients undergoing percutaneous coronary intervention using drug-eluting stents: results from the COronary BIfurcation Stent (COBIS) II registry

Kim M, Ahn Y, Sim D, Hong YJ, Kim J, Jeong M, Gwon H, Kim H, Rha S, Yoon J, Jang Y, Tahk S, Seung K

June 20, 2017 | 10.4244/EIJ-D-16-00264

Coronary interventions

Impact of non-compliant balloons on long-term clinical outcomes in coronary bifurcation lesions: results from the COBIS (COronary BIfurcation Stent) II registry

Park TK, Lee J-H, Song YB, Jeong J-O, Hahn J, Yang J, Choi S, Choi J, Lee S, Jeong M, Kim H, Oh J.H., Yu C, Rha S, Jang Y, Yoon J, Tahk S, Seung K, Park J-S, Gwon H

July 20, 2016 | 10.4244/EIJV12I4A79

Everolimus-eluting versus sirolimus-eluting coronary stents in patients with and without diabetes mellitus

Kang S, Park K, Ahn H-S, Park K, Hong Y, Koo B, Jeong M, Kim H

May 20, 2014 | 10.4244/EIJV10I1A13

Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trial

Kang W, Ahn T, Lee K, Han S, Shin E, Jeong M, Yoon J, Park J-S, Bae J, Hur S, Rha S, Oh S, Kim D, Jang Y, Choi J, Kim B

December 30, 2011 | 10.4244/EIJV7I8A148

Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry

Cuculi F, Banning A, Abizaid A, Bartorelli A, Baux A, Dzavik V, Ellis SG, Gao R, Holmes D, Jeong M, Legrand V, Neumann F, Nyakern M, Spaulding C, Stoll H, Worthley S, Urban P

December 30, 2011 | 10.4244/EIJV7I8A152

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...